Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 39 | 2024 | 46 | 6.770 |
Why?
|
| Parkinson Disease | 29 | 2024 | 89 | 4.910 |
Why?
|
| Subthalamic Nucleus | 19 | 2024 | 22 | 3.640 |
Why?
|
| Humans | 78 | 2025 | 5476 | 1.760 |
Why?
|
| Microelectrodes | 5 | 2025 | 13 | 1.420 |
Why?
|
| Treatment Outcome | 24 | 2024 | 212 | 1.400 |
Why?
|
| Epilepsy, Temporal Lobe | 5 | 2023 | 7 | 1.400 |
Why?
|
| Thalamus | 3 | 2019 | 7 | 1.350 |
Why?
|
| Aged | 35 | 2025 | 859 | 1.230 |
Why?
|
| Female | 43 | 2025 | 2811 | 1.220 |
Why?
|
| Middle Aged | 36 | 2025 | 1098 | 1.210 |
Why?
|
| Brain Mapping | 7 | 2025 | 78 | 1.200 |
Why?
|
| Male | 44 | 2025 | 2765 | 1.180 |
Why?
|
| Tremor | 6 | 2023 | 7 | 1.060 |
Why?
|
| Spinal Cord Stimulation | 4 | 2020 | 6 | 1.050 |
Why?
|
| Neurosurgical Procedures | 4 | 2018 | 13 | 1.040 |
Why?
|
| Streptococcus pyogenes | 3 | 2020 | 4 | 0.960 |
Why?
|
| Cerebral Cortex | 4 | 2025 | 53 | 0.960 |
Why?
|
| Retrospective Studies | 20 | 2024 | 382 | 0.960 |
Why?
|
| Action Potentials | 4 | 2017 | 28 | 0.900 |
Why?
|
| Pain Management | 2 | 2023 | 14 | 0.870 |
Why?
|
| Streptococcal Infections | 3 | 2020 | 4 | 0.850 |
Why?
|
| Electric Stimulation Therapy | 1 | 2023 | 2 | 0.840 |
Why?
|
| Muscle Spasticity | 3 | 2020 | 4 | 0.810 |
Why?
|
| Spinal Cord | 3 | 2024 | 12 | 0.810 |
Why?
|
| Injections, Spinal | 3 | 2020 | 4 | 0.810 |
Why?
|
| Electrodes, Implanted | 9 | 2025 | 20 | 0.810 |
Why?
|
| Essential Tremor | 5 | 2023 | 6 | 0.810 |
Why?
|
| Amygdala | 2 | 2021 | 8 | 0.770 |
Why?
|
| Epilepsy | 5 | 2023 | 34 | 0.760 |
Why?
|
| Nerve Net | 4 | 2021 | 46 | 0.760 |
Why?
|
| Electroencephalography | 6 | 2021 | 134 | 0.700 |
Why?
|
| Brain | 10 | 2024 | 286 | 0.650 |
Why?
|
| Trigeminal Neuralgia | 3 | 2019 | 3 | 0.650 |
Why?
|
| Microvascular Decompression Surgery | 3 | 2019 | 3 | 0.650 |
Why?
|
| Epidemiological Monitoring | 1 | 2019 | 2 | 0.650 |
Why?
|
| Pain | 2 | 2023 | 40 | 0.640 |
Why?
|
| Stereotaxic Techniques | 5 | 2024 | 6 | 0.630 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2024 | 250 | 0.620 |
Why?
|
| Electric Stimulation | 4 | 2024 | 24 | 0.580 |
Why?
|
| Infusion Pumps, Implantable | 2 | 2020 | 3 | 0.560 |
Why?
|
| Analgesics | 1 | 2016 | 7 | 0.520 |
Why?
|
| Neurons | 3 | 2017 | 131 | 0.500 |
Why?
|
| Spinal Cord Injuries | 2 | 2024 | 23 | 0.490 |
Why?
|
| Radiosurgery | 2 | 2016 | 2 | 0.480 |
Why?
|
| Adult | 14 | 2025 | 1683 | 0.480 |
Why?
|
| Antiparkinson Agents | 4 | 2021 | 6 | 0.460 |
Why?
|
| Spinal Nerve Roots | 1 | 2014 | 1 | 0.450 |
Why?
|
| Globus Pallidus | 3 | 2024 | 3 | 0.430 |
Why?
|
| Ventral Thalamic Nuclei | 3 | 2018 | 3 | 0.390 |
Why?
|
| Seizures | 4 | 2023 | 33 | 0.370 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2012 | 37 | 0.370 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2023 | 10 | 0.370 |
Why?
|
| Brain Injuries | 1 | 2012 | 31 | 0.370 |
Why?
|
| Research Design | 1 | 2012 | 35 | 0.370 |
Why?
|
| Disease Progression | 4 | 2023 | 74 | 0.370 |
Why?
|
| Laser Therapy | 2 | 2023 | 8 | 0.360 |
Why?
|
| Prospective Studies | 5 | 2021 | 132 | 0.360 |
Why?
|
| Pilot Projects | 9 | 2021 | 119 | 0.360 |
Why?
|
| Hypoxia, Brain | 1 | 2011 | 1 | 0.350 |
Why?
|
| Surgical Equipment | 1 | 2010 | 1 | 0.350 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 242 | 0.330 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2015 | 19 | 0.330 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2020 | 5 | 0.320 |
Why?
|
| Registries | 4 | 2020 | 24 | 0.320 |
Why?
|
| Antigens, Bacterial | 2 | 2020 | 5 | 0.320 |
Why?
|
| Cohort Studies | 5 | 2024 | 131 | 0.310 |
Why?
|
| Carrier Proteins | 2 | 2020 | 25 | 0.310 |
Why?
|
| Single-Blind Method | 7 | 2021 | 12 | 0.310 |
Why?
|
| Neural Pathways | 3 | 2021 | 41 | 0.300 |
Why?
|
| Child | 7 | 2020 | 657 | 0.300 |
Why?
|
| Muscle Relaxants, Central | 2 | 2020 | 2 | 0.290 |
Why?
|
| Baclofen | 2 | 2020 | 3 | 0.290 |
Why?
|
| Trigeminal Nerve | 3 | 2019 | 3 | 0.290 |
Why?
|
| Brain Stem | 2 | 2018 | 4 | 0.280 |
Why?
|
| Chronic Pain | 2 | 2020 | 23 | 0.280 |
Why?
|
| Cognition Disorders | 3 | 2018 | 46 | 0.270 |
Why?
|
| Epilepsies, Partial | 2 | 2017 | 7 | 0.270 |
Why?
|
| Swine, Miniature | 2 | 2024 | 4 | 0.270 |
Why?
|
| Stroke | 2 | 2022 | 53 | 0.270 |
Why?
|
| Electromyography | 2 | 2024 | 47 | 0.260 |
Why?
|
| Animals | 7 | 2024 | 1817 | 0.250 |
Why?
|
| Genotype | 3 | 2022 | 58 | 0.250 |
Why?
|
| Gait | 2 | 2024 | 47 | 0.230 |
Why?
|
| Electrocorticography | 1 | 2025 | 7 | 0.230 |
Why?
|
| Adolescent | 9 | 2021 | 806 | 0.230 |
Why?
|
| Brain-Computer Interfaces | 1 | 2025 | 16 | 0.230 |
Why?
|
| Brain Neoplasms | 1 | 2025 | 26 | 0.230 |
Why?
|
| Neuropsychological Tests | 6 | 2024 | 176 | 0.220 |
Why?
|
| Anthropology, Cultural | 1 | 2024 | 5 | 0.220 |
Why?
|
| Internship and Residency | 1 | 2024 | 6 | 0.220 |
Why?
|
| Young Adult | 9 | 2021 | 850 | 0.220 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 10 | 0.220 |
Why?
|
| Dystonic Disorders | 2 | 2014 | 2 | 0.220 |
Why?
|
| Equipment Design | 1 | 2024 | 73 | 0.220 |
Why?
|
| Patient-Centered Care | 1 | 2023 | 7 | 0.210 |
Why?
|
| Phantoms, Imaging | 1 | 2024 | 85 | 0.210 |
Why?
|
| White Matter | 1 | 2023 | 24 | 0.200 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2022 | 1 | 0.200 |
Why?
|
| Blood-Brain Barrier | 1 | 2022 | 7 | 0.200 |
Why?
|
| Fiducial Markers | 2 | 2014 | 4 | 0.200 |
Why?
|
| Stroke Rehabilitation | 1 | 2022 | 15 | 0.190 |
Why?
|
| Postoperative Complications | 2 | 2012 | 17 | 0.190 |
Why?
|
| Rats | 3 | 2012 | 251 | 0.190 |
Why?
|
| Health Care Costs | 1 | 2021 | 11 | 0.180 |
Why?
|
| Health Personnel | 1 | 2021 | 22 | 0.180 |
Why?
|
| Wearable Electronic Devices | 1 | 2021 | 18 | 0.180 |
Why?
|
| Walking | 1 | 2022 | 53 | 0.180 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 97 | 0.180 |
Why?
|
| Operative Time | 2 | 2018 | 3 | 0.180 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 90 | 0.180 |
Why?
|
| Basal Nucleus of Meynert | 1 | 2021 | 1 | 0.180 |
Why?
|
| Somatosensory Cortex | 2 | 2012 | 14 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 131 | 0.170 |
Why?
|
| Models, Theoretical | 1 | 2021 | 78 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 57 | 0.170 |
Why?
|
| Hippocampus | 1 | 2021 | 73 | 0.170 |
Why?
|
| Nurse's Role | 1 | 2020 | 1 | 0.170 |
Why?
|
| Desiccation | 1 | 2020 | 1 | 0.170 |
Why?
|
| Microbial Viability | 1 | 2020 | 12 | 0.160 |
Why?
|
| Survival Analysis | 2 | 2016 | 15 | 0.160 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1 | 0.160 |
Why?
|
| Germany | 1 | 2019 | 5 | 0.160 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 6 | 0.160 |
Why?
|
| United States | 3 | 2018 | 521 | 0.160 |
Why?
|
| Mixed Function Oxygenases | 1 | 2019 | 1 | 0.150 |
Why?
|
| Oxidants | 1 | 2019 | 4 | 0.150 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 7 | 0.150 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 148 | 0.150 |
Why?
|
| Leukoencephalopathies | 1 | 2018 | 1 | 0.150 |
Why?
|
| Multiple Sclerosis | 1 | 2019 | 46 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2018 | 2 | 0.150 |
Why?
|
| Cervical Cord | 1 | 2018 | 2 | 0.150 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 9 | 0.140 |
Why?
|
| Neurosurgery | 1 | 2018 | 1 | 0.140 |
Why?
|
| Swine | 3 | 2024 | 51 | 0.140 |
Why?
|
| Neocortex | 1 | 2017 | 1 | 0.140 |
Why?
|
| Synaptic Transmission | 1 | 2017 | 14 | 0.140 |
Why?
|
| Time Factors | 3 | 2015 | 176 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 35 | 0.130 |
Why?
|
| Dexmedetomidine | 1 | 2017 | 2 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2018 | 52 | 0.130 |
Why?
|
| Cerebellum | 2 | 2020 | 10 | 0.130 |
Why?
|
| Anterior Thalamic Nuclei | 1 | 2016 | 1 | 0.130 |
Why?
|
| Oxyhemoglobins | 1 | 2016 | 4 | 0.130 |
Why?
|
| Mood Disorders | 1 | 2016 | 6 | 0.130 |
Why?
|
| Radiculopathy | 1 | 2016 | 1 | 0.130 |
Why?
|
| Temporal Lobe | 1 | 2016 | 19 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 20 | 0.130 |
Why?
|
| Functional Neuroimaging | 1 | 2016 | 15 | 0.130 |
Why?
|
| Spatial Memory | 1 | 2016 | 13 | 0.130 |
Why?
|
| Frontal Lobe | 1 | 2016 | 16 | 0.130 |
Why?
|
| Cognition | 3 | 2024 | 174 | 0.120 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 39 | 0.120 |
Why?
|
| Memory, Short-Term | 1 | 2016 | 49 | 0.120 |
Why?
|
| Cloud Computing | 1 | 2015 | 3 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 12 | 0.120 |
Why?
|
| Computer Communication Networks | 1 | 2015 | 7 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 320 | 0.120 |
Why?
|
| Research | 1 | 2015 | 10 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 13 | 0.120 |
Why?
|
| Atlases as Topic | 1 | 2014 | 3 | 0.110 |
Why?
|
| Patient Selection | 1 | 2014 | 10 | 0.110 |
Why?
|
| Surgical Wound Infection | 1 | 2014 | 2 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 73 | 0.110 |
Why?
|
| Prosthesis Implantation | 1 | 2014 | 2 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2014 | 17 | 0.110 |
Why?
|
| Craniocerebral Trauma | 1 | 2013 | 2 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2014 | 188 | 0.100 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 2 | 0.100 |
Why?
|
| Confusion | 1 | 2012 | 1 | 0.100 |
Why?
|
| Lateral Ventricles | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cortical Synchronization | 1 | 2012 | 5 | 0.100 |
Why?
|
| Consciousness | 1 | 2012 | 12 | 0.100 |
Why?
|
| Reference Values | 1 | 2012 | 28 | 0.100 |
Why?
|
| Child, Preschool | 3 | 2020 | 187 | 0.090 |
Why?
|
| Biomechanical Phenomena | 2 | 2024 | 176 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 71 | 0.090 |
Why?
|
| Patients | 1 | 2012 | 1 | 0.090 |
Why?
|
| Informed Consent | 1 | 2012 | 2 | 0.090 |
Why?
|
| Research Subjects | 1 | 2012 | 2 | 0.090 |
Why?
|
| Evoked Potentials | 1 | 2012 | 29 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2012 | 19 | 0.090 |
Why?
|
| Decision Making | 1 | 2012 | 12 | 0.090 |
Why?
|
| Algorithms | 1 | 2014 | 276 | 0.090 |
Why?
|
| Perioperative Period | 1 | 2011 | 1 | 0.090 |
Why?
|
| Neurologic Examination | 1 | 2011 | 3 | 0.090 |
Why?
|
| Speech Disorders | 1 | 2011 | 5 | 0.090 |
Why?
|
| Comprehension | 1 | 2012 | 33 | 0.090 |
Why?
|
| Craniotomy | 1 | 2011 | 2 | 0.090 |
Why?
|
| Cerebral Arteries | 1 | 2011 | 2 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2018 | 115 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2012 | 55 | 0.090 |
Why?
|
| Microsurgery | 1 | 2011 | 6 | 0.090 |
Why?
|
| Carotid Artery Diseases | 1 | 2011 | 1 | 0.090 |
Why?
|
| Carotid Stenosis | 1 | 2011 | 1 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2011 | 1 | 0.090 |
Why?
|
| Angioplasty | 1 | 2011 | 1 | 0.090 |
Why?
|
| Femoral Artery | 1 | 2011 | 2 | 0.090 |
Why?
|
| Popliteal Artery | 1 | 2011 | 2 | 0.090 |
Why?
|
| Alloys | 1 | 2011 | 2 | 0.090 |
Why?
|
| Ischemia | 1 | 2011 | 4 | 0.090 |
Why?
|
| Stents | 1 | 2011 | 4 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 19 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 9 | 0.090 |
Why?
|
| Implantable Neurostimulators | 1 | 2010 | 2 | 0.090 |
Why?
|
| Movement Disorders | 1 | 2010 | 2 | 0.090 |
Why?
|
| Insulin | 1 | 2011 | 31 | 0.090 |
Why?
|
| Voltage-Sensitive Dye Imaging | 1 | 2010 | 4 | 0.080 |
Why?
|
| Logistic Models | 2 | 2021 | 69 | 0.080 |
Why?
|
| Limbic System | 2 | 2021 | 3 | 0.080 |
Why?
|
| Functional Laterality | 2 | 2021 | 38 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2018 | 96 | 0.070 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2016 | 19 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 277 | 0.060 |
Why?
|
| Ultrasonic Therapy | 1 | 2024 | 1 | 0.060 |
Why?
|
| Printing, Three-Dimensional | 1 | 2024 | 9 | 0.060 |
Why?
|
| Hindlimb | 1 | 2024 | 4 | 0.060 |
Why?
|
| Models, Animal | 1 | 2024 | 25 | 0.050 |
Why?
|
| Wakefulness | 1 | 2023 | 10 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2024 | 126 | 0.050 |
Why?
|
| Lasers | 1 | 2023 | 9 | 0.050 |
Why?
|
| Levodopa | 1 | 2022 | 3 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 8 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 13 | 0.050 |
Why?
|
| Vagus Nerve | 1 | 2022 | 1 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2022 | 4 | 0.050 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 66 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 6 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 18 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2022 | 15 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2022 | 20 | 0.050 |
Why?
|
| Muscles | 1 | 2022 | 6 | 0.050 |
Why?
|
| Risk Factors | 2 | 2014 | 184 | 0.050 |
Why?
|
| Costs and Cost Analysis | 1 | 2021 | 7 | 0.050 |
Why?
|
| Finite Element Analysis | 1 | 2021 | 8 | 0.040 |
Why?
|
| Physics | 1 | 2021 | 5 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 136 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 39 | 0.040 |
Why?
|
| Arousal | 1 | 2021 | 7 | 0.040 |
Why?
|
| Electric Power Supplies | 1 | 2020 | 4 | 0.040 |
Why?
|
| Neuroscience Nursing | 1 | 2020 | 1 | 0.040 |
Why?
|
| Pharyngitis | 1 | 2020 | 1 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2021 | 44 | 0.040 |
Why?
|
| Infant | 1 | 2020 | 87 | 0.040 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2019 | 1 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2019 | 18 | 0.040 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2019 | 32 | 0.040 |
Why?
|
| Anisotropy | 1 | 2018 | 18 | 0.040 |
Why?
|
| Temperature | 1 | 2019 | 62 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 24 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2018 | 5 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2019 | 58 | 0.040 |
Why?
|
| Oxygen | 1 | 2018 | 21 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2017 | 6 | 0.030 |
Why?
|
| Neurocognitive Disorders | 1 | 2017 | 6 | 0.030 |
Why?
|
| Piperidines | 1 | 2017 | 17 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 7 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2016 | 1 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2016 | 17 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 7 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2016 | 25 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 13 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2014 | 7 | 0.030 |
Why?
|
| Povidone-Iodine | 1 | 2014 | 1 | 0.030 |
Why?
|
| Wound Closure Techniques | 1 | 2014 | 1 | 0.030 |
Why?
|
| Chlorhexidine | 1 | 2014 | 2 | 0.030 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 2 | 0.030 |
Why?
|
| Skin Diseases | 1 | 2014 | 3 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2014 | 5 | 0.030 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2014 | 3 | 0.030 |
Why?
|
| Infection Control | 1 | 2014 | 4 | 0.030 |
Why?
|
| Incidence | 1 | 2014 | 33 | 0.030 |
Why?
|
| Surgeons | 1 | 2014 | 6 | 0.030 |
Why?
|
| Comorbidity | 1 | 2014 | 49 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 350 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2012 | 21 | 0.020 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2012 | 4 | 0.020 |
Why?
|
| Sweden | 1 | 2011 | 1 | 0.020 |
Why?
|
| Vascular Patency | 1 | 2011 | 1 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2011 | 1 | 0.020 |
Why?
|
| Limb Salvage | 1 | 2011 | 1 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 7 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 16 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 30 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 30 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 23 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2011 | 27 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 26 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 75 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 49 | 0.020 |
Why?
|
| Infrared Rays | 1 | 2010 | 8 | 0.020 |
Why?
|